Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma

被引:0
|
作者
Li, Guangyao [1 ]
Atiq, Warda [2 ]
Hashmi, Muhammad Furqan [3 ]
Ibrahim, Shebl Salah [4 ]
Abdulsalam, Kholoud Abdulrhman Al [5 ]
Kadham, Mustafa Jawad [6 ]
Al-Azzawi, Abdul Kareem J. [7 ]
Aufy, Mohammed [8 ]
Abdel-Maksoud, Mostafa A. [9 ,10 ]
机构
[1] Second Peoples Hosp Wuhu, Dept Gastrointestinal Surg, Wuhu, Anhui, Peoples R China
[2] Fatima Jinnah Med Univ, Lahore, Pakistan
[3] Sharif Med & Dent Coll, Lahore, Pakistan
[4] King Saud Univ, Dept Biochem, Riyadh, Saudi Arabia
[5] King Saud Univ, Coll Food & Agr Sci, Dept Food Sci & Nutr, Riyadh, Saudi Arabia
[6] Al Farahidi Univ, Coll Med Tech, Baghdad, Iraq
[7] Al Turath Univ Coll, Baghdad, Iraq
[8] Univ Vienna, Dept Pharmaceut Sci, Div Pharmacol & Toxicol, Vienna, Austria
[9] King Saud Univ, Coll Sci, Dept Bot & Microbiol, PO 2455, Riyadh 11451, Saudi Arabia
[10] King Saud Univ, Coll Sci, Dept Bot & Microbiol, PO 2455, Riyadh 11451, Saudi Arabia
来源
关键词
Lung adenocarcinoma; hub genes; biomarkers; chemotherapeutic drugs; EXPRESSION OMNIBUS; PROGNOSTIC-FACTORS; TISSUE INHIBITOR; BREAST-CANCER; SERUM-LEVELS; TUMOR; TIMP1; INTERLEUKIN-6; OSTEOPONTIN; CLASSIFICATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Lung adenocarcinoma (LUAD) is recognized as one of the most prevalent and deadliest malignancies around the globe. The molecular mechanisms behind LUAD have not been fully elucidated. This study was launched to explore LUAD-associated hub genes and their enriched pathways using bioinformatics methods. Methods: Information on GSE10072 was retrieved from the Gene Expression Omnibus (GEO) database and analyzed via the Limma package-based GEO2R tool to obtain the top 100 differentially expressed genes (DEGs) in LUAD. The protein-protein interaction (PPI) network of the DEGs was drawn using the STRING website and was shifted into Cytoscape to screen the top 6 hub genes via the CytoHubba application. Furthermore, the expression analysis and validation of hub genes in LUAD samples and cell lines were done using UALCAN, OncoDB, and GENT2 databases. Moreover, OncoDB was also used for analyzing hub gene DNA methylation levels. In addition, cBioPortal, GSEA tool, Kaplan-Meier (KM) plotter, Enrichr, CancerSEA, and DGIdb were performed to explore some other important aspects of hub genes in LUAD. Results: We identified Interleukin 6 (IL6), Collagen, type I, alpha 1 (COL1A1), TIMP metallopeptidase inhibitor 1 (TIMP1), CD34 molecule (CD34), Decorin (DCN), and Secreted Phosphoprotein 1 (SPP1) genes as the hub genes in LUAD, out of which IL6, CD34, and DCN were significantly down-regulated while COL1A1, TIMP1, and SPP1 were significantly up-regulated in LUAD cell lines and samples of diverse clinical variables. In this study, we also documented some important correlations between hub genes and other parameters such as DNA methylation, genetic alterations, Overall Survival (OS), and 14 important states at the single cell level. Lastly, we also identified hub genes associated with the ceRNA network and 11 important chemotherapeutic drugs. Conclusion: We identified 6 hub genes involved in the development and progression of LUAD. These hub genes can also be helpful in the accurate detection of LUAD and provide novel ideas for treatment.
引用
收藏
页码:1550 / 1568
页数:19
相关论文
共 50 条
  • [1] Multi-omics analysis of molecular landscape and heterogeneity in fetal adenocarcinoma of the lung
    Guo, Wei
    Sun, Li
    Chen, Xiaoxi
    Zhou, Haitao
    Yan, Shi
    Zhao, Gang
    Tang, Haimeng
    Bao, Hua
    Wu, Xue
    Shao, Yang
    Lin, Lin
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Identification and validation of the mitochondrial function related hub genes by unsupervised machine learning and multi-omics analyses in lung adenocarcinoma
    Jin, Xing
    Zhang, Huan
    Sui, Qihai
    Li, Ming
    Liang, Jiaqi
    Hu, Zhengyang
    Cheng, Ye
    Zheng, Yuansheng
    Chen, Zhencong
    Lin, Miao
    Wang, Hao
    Zhan, Cheng
    HELIYON, 2022, 8 (12)
  • [3] Exploration of the hub genes and miRNAs in lung adenocarcinoma
    Zhai, Yuanyuan
    Chen, Yingli
    Li, Qianzhong
    Zhang, Luqiang
    ONCOLOGY LETTERS, 2019, 18 (02) : 1713 - 1722
  • [4] Multi-omics landscape of circadian rhythm pathway alterations in Glioma
    Zhang, Chang
    Xu, Jiahui
    Chen, Lijun
    Lin, Xiaojie
    BIOENGINEERED, 2021, 12 (01) : 3294 - 3308
  • [5] Uncovering Prognosis-related Genes and Pathways by Multi-omics Analysis in Lung Adenocarcinoma
    Asada, Ken
    Kobayashi, Kazuma
    Takahashi, Satoshi
    Takasawa, Ken
    Komatsu, Masaaki
    Kaneko, Syuzo
    Sese, Jun
    Hamamoto, Ryuji
    CANCER SCIENCE, 2021, 112 : 444 - 444
  • [6] Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma
    Quanyou Wu
    Lin Feng
    Yaru Wang
    Yousheng Mao
    Xuebing Di
    Kaitai Zhang
    Shujun Cheng
    Ting Xiao
    Signal Transduction and Targeted Therapy, 7
  • [7] Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma
    Wu, Quanyou
    Feng, Lin
    Wang, Yaru
    Mao, Yousheng
    Di, Xuebing
    Zhang, Kaitai
    Cheng, Shujun
    Xiao, Ting
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [8] Multi-omics analysis of Japanese lung adenocarcinoma including mitochondria omics data
    Asada, Ken
    Bolatkan, Amina
    Shiraishi, Kouya
    Horinouchi, Hidehito
    Yoshida, Yukihiro
    Mukai, Masami
    Yatabe, Yasushi
    Kohno, Takashi
    Hamamoto, Ryuji
    CANCER SCIENCE, 2025, 116 : 106 - 106
  • [9] Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung Adenocarcinoma
    Wang, Zhaoxi
    Wei, Yongyue
    Zhang, Ruyang
    Su, Li
    Gogarten, Stephanie M.
    Liu, Geoffrey
    Brennan, Paul
    Field, John K.
    McKay, James D.
    Lissowska, Jolanta
    Swiatkowska, Beata
    Janout, Vladimir
    Bolca, Ciprian
    Kontic, Milica
    Scelo, Ghislaine
    Zaridze, David
    Laurie, Cathy C.
    Doheny, Kimberly F.
    Pugh, Elizabeth K.
    Marosy, Beth A.
    Hetrick, Kurt N.
    Xiao, Xiangjun
    Pikielny, Claudio
    Hung, Rayjean J.
    Amos, Christopher I.
    Lin, Xihong
    Christiani, David C.
    EBIOMEDICINE, 2018, 32 : 93 - 101
  • [10] Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma
    Zhao, Yue
    Gao, Yakun
    Xu, Xiaodong
    Zhou, Jiwu
    Wang, He
    BMC CANCER, 2021, 21 (01)